Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group (Q43286770)
Jump to navigation
Jump to search
scientific article published on 24 August 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group |
scientific article published on 24 August 2009 |
Statements
1 reference
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group (English)
1 reference
Carmen Schade-Brittinger
1 reference
Anja Rinke
1 reference
Hans-Helge Müller
1 reference
Klaus-Jochen Klose
1 reference
Peter Barth
1 reference
Matthias Wied
1 reference
Christina Mayer
1 reference
Behnaz Aminossadati
1 reference
Ulrich-Frank Pape
1 reference
Michael Bläker
1 reference
Jan Harder
1 reference
Christian Arnold
1 reference
Rudolf Arnold
1 reference
PROMID Study Group
1 reference
24 August 2009
1 reference
1 reference
Identifiers
1 reference